Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1992 Jul;5(3):275–301. doi: 10.1128/cmr.5.3.275

Hepatitis B virus infection and primary hepatocellular carcinoma.

M Feitelson 1
PMCID: PMC358245  PMID: 1323384

Abstract

For many years, epidemiological studies have demonstrated a strong link between chronic hepatitis B virus (HBV) infection and the development of primary hepatocellular carcinoma (PHC). Other hepatocarcinogens such as hepatitis C virus and aflatoxin also contribute to hepatocarcinogenesis either in conjunction with HBV infection or alone. Cellular and molecular biological studies are providing explanations for the HBV-PHC relationship, and models are now being formulated to further test the relative importance of various factors such as viral DNA integration, activation of oncogenes, genetic instability, loss of tumor suppressor genes, and trans-activating properties of HBV to the pathogenesis of PHC. Further research will probably define more than a single mechanism whereby chronic HBV infection results in PHC.

Full text

PDF
275

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akahane Y., Yamanaka T., Suzuki H., Sugai Y., Tsuda F., Yotsumoto S., Omi S., Okamoto H., Miyakawa Y., Mayumi M. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology. 1990 Oct;99(4):1113–1119. doi: 10.1016/0016-5085(90)90632-b. [DOI] [PubMed] [Google Scholar]
  2. Alberti A., Pontisso P., Chemello L., Schiavon E., Realdi G. Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection. Prog Clin Biol Res. 1983;143:327–336. [PubMed] [Google Scholar]
  3. Alberti A., Realdi G., Tremolada F., Spina G. P. Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. Clin Exp Immunol. 1976 Sep;25(3):396–402. [PMC free article] [PubMed] [Google Scholar]
  4. Almeida J. D., Rubenstein D., Stott E. J. New antigen-antibody system in Australia-antigen-positive hepatitis. Lancet. 1971 Dec 4;2(7736):1225–1227. doi: 10.1016/s0140-6736(71)90543-5. [DOI] [PubMed] [Google Scholar]
  5. Antonucci T. K., Rutter W. J. Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol. 1989 Feb;63(2):579–583. doi: 10.1128/jvi.63.2.579-583.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Araki K., Miyazaki J., Hino O., Tomita N., Chisaka O., Matsubara K., Yamamura K. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A. 1989 Jan;86(1):207–211. doi: 10.1073/pnas.86.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Aufiero B., Schneider R. J. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 1990 Feb;9(2):497–504. doi: 10.1002/j.1460-2075.1990.tb08136.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bagchi S., Raychaudhuri P., Nevins J. R. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell. 1990 Aug 24;62(4):659–669. doi: 10.1016/0092-8674(90)90112-r. [DOI] [PubMed] [Google Scholar]
  9. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  10. Barrett J. C. A National Institutes of Health Workshop Report. Cellular and molecular mechanisms for suppression and reversion of tumorigenicity. A Chemical Pathology Study Section workshop. Cancer Res. 1987 May 1;47(9):2514–2520. [PubMed] [Google Scholar]
  11. Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973 Oct 27;2(7835):926–929. doi: 10.1016/s0140-6736(73)92594-4. [DOI] [PubMed] [Google Scholar]
  12. Bavand M. R., Laub O. Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles. J Virol. 1988 Feb;62(2):626–628. doi: 10.1128/jvi.62.2.626-628.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bavand M., Feitelson M., Laub O. The hepatitis B virus-associated reverse transcriptase is encoded by the viral pol gene. J Virol. 1989 Feb;63(2):1019–1021. doi: 10.1128/jvi.63.2.1019-1021.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Beard J. W., Hillman E. A., Beard D., Lapis K., Heine U. Neoplastic response of the avian liver to host infection with strain Mc29 leukosis verus. Cancer Res. 1975 Jul;35(7):1603–1627. [PubMed] [Google Scholar]
  15. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  16. Beasley R. P., Shiao I. S., Wu T. C., Hwang L. Y. Hepatoma in an HBsAg carrier--seven years after perinatal infection. J Pediatr. 1982 Jul;101(1):83–84. doi: 10.1016/s0022-3476(82)80190-x. [DOI] [PubMed] [Google Scholar]
  17. Benedict W. F., Murphree A. L., Banerjee A., Spina C. A., Sparkes M. C., Sparkes R. S. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science. 1983 Feb 25;219(4587):973–975. doi: 10.1126/science.6336308. [DOI] [PubMed] [Google Scholar]
  18. Blanquet V., Garreau F., Chenivesse X., Brechot C., Turleau C. Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer. Hum Genet. 1988 Nov;80(3):274–276. doi: 10.1007/BF01790096. [DOI] [PubMed] [Google Scholar]
  19. Blum H. E., Stowring L., Figus A., Montgomery C. K., Haase A. T., Vyas G. N. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6685–6688. doi: 10.1073/pnas.80.21.6685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Blumberg B. S., London W. T. Hepatitis B virus and the prevention of primary cancer of the liver. J Natl Cancer Inst. 1985 Feb;74(2):267–273. [PubMed] [Google Scholar]
  21. Blumberg B. S., London W. T. Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. Cancer. 1982 Dec 1;50(11 Suppl):2657–2665. [PubMed] [Google Scholar]
  22. Blumberg B. S., Millman I., Venkateswaran P. S., Thyagarajan S. P. Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus. Cancer Detect Prev. 1989;14(2):195–201. [PubMed] [Google Scholar]
  23. Bortolotti F., Alberti A., Cadrobbi P., Rugge M., Armigliato M., Realdi G. Prognostic value of hepatitis B core antigen (HBcAg) expression in the liver of children with chronic hepatitis type B. Liver. 1985 Feb;5(1):40–47. doi: 10.1111/j.1600-0676.1985.tb00014.x. [DOI] [PubMed] [Google Scholar]
  24. Bowcock A. M., Pinto M. R., Bey E., Kuyl J. M., Dusheiko G. M., Bernstein R. The PLC/PRF/5 human hepatoma cell line. II. Chromosomal assignment of hepatitis B virus integration sites. Cancer Genet Cytogenet. 1985 Sep;18(1):19–26. doi: 10.1016/0165-4608(85)90034-2. [DOI] [PubMed] [Google Scholar]
  25. Brand N., Petkovich M., Krust A., Chambon P., de Thé H., Marchio A., Tiollais P., Dejean A. Identification of a second human retinoic acid receptor. Nature. 1988 Apr 28;332(6167):850–853. doi: 10.1038/332850a0. [DOI] [PubMed] [Google Scholar]
  26. Bressac B., Galvin K. M., Liang T. J., Isselbacher K. J., Wands J. R., Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1973–1977. doi: 10.1073/pnas.87.5.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  28. Bruss V., Gerlich W. H. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology. 1988 Apr;163(2):268–275. doi: 10.1016/0042-6822(88)90266-8. [DOI] [PubMed] [Google Scholar]
  29. Bréchot C., Hadchouel M., Scotto J., Fonck M., Potet F., Vyas G. N., Tiollais P. State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3906–3910. doi: 10.1073/pnas.78.6.3906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Buetow K. H., Murray J. C., Israel J. L., London W. T., Smith M., Kew M., Blanquet V., Brechot C., Redeker A., Govindarajah S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8852–8856. doi: 10.1073/pnas.86.22.8852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bullock P., Champoux J. J., Botchan M. Association of crossover points with topoisomerase I cleavage sites: a model for nonhomologous recombination. Science. 1985 Nov 22;230(4728):954–958. doi: 10.1126/science.2997924. [DOI] [PubMed] [Google Scholar]
  32. Bullock P., Forrester W., Botchan M. DNA sequence studies of simian virus 40 chromosomal excision and integration in rat cells. J Mol Biol. 1984 Mar 25;174(1):55–84. doi: 10.1016/0022-2836(84)90365-6. [DOI] [PubMed] [Google Scholar]
  33. Burrell C. J., Gowans E. J., Rowland R., Hall P., Jilbert A. R., Marmion B. P. Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology. 1984 Jan-Feb;4(1):20–24. doi: 10.1002/hep.1840040104. [DOI] [PubMed] [Google Scholar]
  34. Bänninger P., Altorfer J., Frösner G. G., Pirovino M., Gudat F., Bianchi L., Grob P. J., Schmid M. Prevalence and significance of anti-HBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors. Hepatology. 1983 May-Jun;3(3):337–342. doi: 10.1002/hep.1840030310. [DOI] [PubMed] [Google Scholar]
  35. Cairns J. The origin of human cancers. Nature. 1981 Jan 29;289(5796):353–357. doi: 10.1038/289353a0. [DOI] [PubMed] [Google Scholar]
  36. Cariani E., Lasserre C., Seurin D., Hamelin B., Kemeny F., Franco D., Czech M. P., Ullrich A., Brechot C. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res. 1988 Dec 1;48(23):6844–6849. [PubMed] [Google Scholar]
  37. Cariani E., Seurin D., Lasserre C., Franco D., Binoux M., Brechot C. Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis. J Hepatol. 1990 Sep;11(2):226–231. doi: 10.1016/0168-8278(90)90118-b. [DOI] [PubMed] [Google Scholar]
  38. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989 Sep 9;2(8663):588–591. doi: 10.1016/s0140-6736(89)90713-7. [DOI] [PubMed] [Google Scholar]
  39. Caselmann W. H., Meyer M., Kekulé A. S., Lauer U., Hofschneider P. H., Koshy R. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A. 1990 Apr;87(8):2970–2974. doi: 10.1073/pnas.87.8.2970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Castilla A., Prieto J., Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med. 1991 Apr 4;324(14):933–940. doi: 10.1056/NEJM199104043241401. [DOI] [PubMed] [Google Scholar]
  41. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  42. Chang H. K., Ting L. P. The surface gene promoter of the human hepatitis B virus displays a preference for differentiated hepatocytes. Virology. 1989 May;170(1):176–183. doi: 10.1016/0042-6822(89)90364-4. [DOI] [PubMed] [Google Scholar]
  43. Chang M. H., Hsu H. C., Lee C. Y., Chen D. S., Lee C. H., Lin K. S. Fraternal hepatocellular carcinoma in young children in two families. Cancer. 1984 Apr 15;53(8):1807–1810. doi: 10.1002/1097-0142(19840415)53:8<1807::aid-cncr2820530835>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  44. Chen D. S., Kuo G. C., Sung J. L., Lai M. Y., Sheu J. C., Chen P. J., Yang P. M., Hsu H. M., Chang M. H., Chen C. J. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990 Oct;162(4):817–822. doi: 10.1093/infdis/162.4.817. [DOI] [PubMed] [Google Scholar]
  45. Chen M. L., Lee Y. H., Lo S. J. High-level production of hepatitis B viral X protein in Escherichia coli using gene II promoter of bacteriophage M13. Gene. 1988;62(2):315–321. doi: 10.1016/0378-1119(88)90568-9. [DOI] [PubMed] [Google Scholar]
  46. Chisari F. V., Filippi P., Buras J., McLachlan A., Popper H., Pinkert C. A., Palmiter R. D., Brinster R. L. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6909–6913. doi: 10.1073/pnas.84.19.6909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Chisari F. V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H. A., Sell S., Pinkert C. A., Brinster R. L., Palmiter R. D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989 Dec 22;59(6):1145–1156. doi: 10.1016/0092-8674(89)90770-8. [DOI] [PubMed] [Google Scholar]
  48. Choo K. B., Liu M. S., Chang P. C., Wu S. M., Su M. W., Pan C. C., Han S. H. Analysis of six distinct integrated hepatitis B virus sequences cloned from the cellular DNA of a human hepatocellular carcinoma. Virology. 1986 Oct 30;154(2):405–408. doi: 10.1016/0042-6822(86)90467-8. [DOI] [PubMed] [Google Scholar]
  49. Chu C. M., Karayiannis P., Fowler M. J., Monjardino J., Liaw Y. F., Thomas H. C. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology. 1985 May-Jun;5(3):431–434. doi: 10.1002/hep.1840050315. [DOI] [PubMed] [Google Scholar]
  50. Chu C. M., Liaw Y. F. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology. 1987 Jan;92(1):220–225. doi: 10.1016/0016-5085(87)90863-8. [DOI] [PubMed] [Google Scholar]
  51. Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science. 1990 Aug 31;249(4972):1007–1011. doi: 10.1126/science.2204108. [DOI] [PubMed] [Google Scholar]
  52. Colgrove R., Simon G., Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol. 1989 Sep;63(9):4019–4026. doi: 10.1128/jvi.63.9.4019-4026.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Colombo M., Kuo G., Choo Q. L., Donato M. F., Del Ninno E., Tommasini M. A., Dioguardi N., Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989 Oct 28;2(8670):1006–1008. doi: 10.1016/s0140-6736(89)91016-7. [DOI] [PubMed] [Google Scholar]
  54. Cooper G. M. Cellular transforming genes. Science. 1982 Aug 27;217(4562):801–806. doi: 10.1126/science.6285471. [DOI] [PubMed] [Google Scholar]
  55. Cote P. J., Korba B. E., Steinberg H., Ramirez-Mejia C., Baldwin B., Hornbuckle W. E., Tennant B. C., Gerin J. L. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J Immunol. 1991 May 1;146(9):3138–3144. [PubMed] [Google Scholar]
  56. Cova L., Wild C. P., Mehrotra R., Turusov V., Shirai T., Lambert V., Jacquet C., Tomatis L., Trépo C., Montesano R. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks. Cancer Res. 1990 Apr 1;50(7):2156–2163. [PubMed] [Google Scholar]
  57. D'Andrea A. D., Haseltine W. A. Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4120–4124. doi: 10.1073/pnas.75.9.4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. De Flora S., Hietanen E., Bartsch H., Camoirano A., Izzotti A., Bagnasco M., Millman I. Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. Carcinogenesis. 1989 Jun;10(6):1099–1106. doi: 10.1093/carcin/10.6.1099. [DOI] [PubMed] [Google Scholar]
  59. De Flora S., Romano M., Basso C., Serra D., Astengo M., Picciotto A. Metabolic activation of hepatocarcinogens in chronic hepatitis B. Mutat Res. 1985 Nov;144(3):213–219. doi: 10.1016/0165-7992(85)90143-5. [DOI] [PubMed] [Google Scholar]
  60. DeCaprio J. A., Ludlow J. W., Figge J., Shew J. Y., Huang C. M., Lee W. H., Marsilio E., Paucha E., Livingston D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 1988 Jul 15;54(2):275–283. doi: 10.1016/0092-8674(88)90559-4. [DOI] [PubMed] [Google Scholar]
  61. Dejean A., Bougueleret L., Grzeschik K. H., Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature. 1986 Jul 3;322(6074):70–72. doi: 10.1038/322070a0. [DOI] [PubMed] [Google Scholar]
  62. Dejean A., Lugassy C., Zafrani S., Tiollais P., Brechot C. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol. 1984 Mar;65(Pt 3):651–655. doi: 10.1099/0022-1317-65-3-651. [DOI] [PubMed] [Google Scholar]
  63. Dejean A., Sonigo P., Wain-Hobson S., Tiollais P. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5350–5354. doi: 10.1073/pnas.81.17.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Dejean A., de Thé H. Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. Mol Biol Med. 1990 Jun;7(3):213–222. [PubMed] [Google Scholar]
  65. Dempo K., Chisaka N., Yoshida Y., Kaneko A., Onoé T. Immunofluorescent study on alpha-fetoprotein-producing cells in the early stage of 3'-methyl-4-dimethylaminoazobenzene carcinogenesis. Cancer Res. 1975 May;35(5):1282–1287. [PubMed] [Google Scholar]
  66. Dienes H. P., Gerlich W. H., Wörsdörfer M., Gerken G., Bianchi L., Hess G., Meyer zum Büschenfelde K. H. Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B. Gastroenterology. 1990 Apr;98(4):1017–1023. doi: 10.1016/0016-5085(90)90028-y. [DOI] [PubMed] [Google Scholar]
  67. Dragani T. A., Manenti G., Farza H., Della Porta G., Tiollais P., Pourcel C. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis. 1990 Jun;11(6):953–956. doi: 10.1093/carcin/11.6.953. [DOI] [PubMed] [Google Scholar]
  68. Duffy M. J., Duffy G. J. Estradiol receptors in human liver. J Steroid Biochem. 1978 Mar;9(3):233–235. doi: 10.1016/0022-4731(78)90154-1. [DOI] [PubMed] [Google Scholar]
  69. Dusheiko G. M., Hoofnagle J. H., Cooksley W. G., James S. P., Jones E. A. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest. 1983 May;71(5):1104–1113. doi: 10.1172/JCI110860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Eddleston A. L., Williams R. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet. 1974 Dec 28;2(7896):1543–1545. doi: 10.1016/s0140-6736(74)90287-6. [DOI] [PubMed] [Google Scholar]
  71. Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med. 1976 Feb 26;294(9):470–472. doi: 10.1056/NEJM197602262940904. [DOI] [PubMed] [Google Scholar]
  72. Elfassi E., Haseltine W. A., Dienstag J. L. Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector. Proc Natl Acad Sci U S A. 1986 Apr;83(7):2219–2222. doi: 10.1073/pnas.83.7.2219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Etiemble J., Möröy T., Jacquemin E., Tiollais P., Buendia M. A. Fused transcripts of c-myc and a new cellular locus, hcr in a primary liver tumor. Oncogene. 1989 Jan;4(1):51–57. [PubMed] [Google Scholar]
  74. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. FARBER E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956 Feb;16(2):142–148. [PubMed] [Google Scholar]
  76. Faktor O., De-Medina T., Shaul Y. Regulation of hepatitis B virus S gene promoter in transfected cell lines. Virology. 1988 Feb;162(2):362–368. doi: 10.1016/0042-6822(88)90476-x. [DOI] [PubMed] [Google Scholar]
  77. Faktor O., Shaul Y. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene. 1990 Jun;5(6):867–872. [PubMed] [Google Scholar]
  78. Farber E. Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. Cancer Res. 1984 Dec;44(12 Pt 1):5463–5474. [PubMed] [Google Scholar]
  79. Farber E., Sarma D. S. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest. 1987 Jan;56(1):4–22. [PubMed] [Google Scholar]
  80. Farrell G. C., Joshua D. E., Uren R. F., Baird P. J., Perkins K. W., Kronenberg H. Androgen-induced hepatoma. Lancet. 1975 Feb 22;1(7904):430–432. doi: 10.1016/s0140-6736(75)91494-4. [DOI] [PubMed] [Google Scholar]
  81. Farza H., Hadchouel M., Scotto J., Tiollais P., Babinet C., Pourcel C. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol. 1988 Nov;62(11):4144–4152. doi: 10.1128/jvi.62.11.4144-4152.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Farza H., Salmon A. M., Hadchouel M., Moreau J. L., Babinet C., Tiollais P., Pourcel C. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1187–1191. doi: 10.1073/pnas.84.5.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Fausto N., Mead J. E. Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest. 1989 Jan;60(1):4–13. [PubMed] [Google Scholar]
  84. Fausto N., Shank P. R. Oncogene expression in liver regeneration and hepatocarcinogenesis. Hepatology. 1983 Nov-Dec;3(6):1016–1023. doi: 10.1002/hep.1840030621. [DOI] [PubMed] [Google Scholar]
  85. Feitelson M. A., Clayton M. M., Blumberg B. S. X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum. Gastroenterology. 1990 Apr;98(4):1071–1078. doi: 10.1016/0016-5085(90)90035-y. [DOI] [PubMed] [Google Scholar]
  86. Feitelson M. A., Clayton M. M. X antigen polypeptides in the sera of hepatitis B virus-infected patients. Virology. 1990 Jul;177(1):367–371. doi: 10.1016/0042-6822(90)90492-a. [DOI] [PubMed] [Google Scholar]
  87. Feitelson M. A., Clayton M. M. X antigen/antibody markers in hepadnavirus infections. Antibodies to the X gene product(s). Gastroenterology. 1990 Aug;99(2):500–507. doi: 10.1016/0016-5085(90)91033-3. [DOI] [PubMed] [Google Scholar]
  88. Feitelson M. A., DeTolla L. J., Zhou X. D. A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA. J Virol. 1988 Apr;62(4):1408–1415. doi: 10.1128/jvi.62.4.1408-1415.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Feitelson M. A. Hepatitis B virus gene products as immunological targets in chronic infection. Mol Biol Med. 1989 Oct;6(5):367–393. [PubMed] [Google Scholar]
  90. Feitelson M. A., Marion P. L., Robinson W. S. The nature of polypeptides larger in size than the major surface antigen components of hepatitis b and like viruses in ground squirrels, woodchucks, and ducks. Virology. 1983 Oct 15;130(1):76–90. doi: 10.1016/0042-6822(83)90119-8. [DOI] [PubMed] [Google Scholar]
  91. Feitelson M. A. Products of the "X" gene in hepatitis B and related viruses. Hepatology. 1986 Mar-Apr;6(2):191–198. doi: 10.1002/hep.1840060207. [DOI] [PubMed] [Google Scholar]
  92. Ferenci P., Dragosics B., Marosi L., Kiss F. Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations. Liver. 1984 Feb;4(1):7–14. doi: 10.1111/j.1600-0676.1984.tb00901.x. [DOI] [PubMed] [Google Scholar]
  93. Finlay C. A., Hinds P. W., Levine A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989 Jun 30;57(7):1083–1093. doi: 10.1016/0092-8674(89)90045-7. [DOI] [PubMed] [Google Scholar]
  94. Foster P. L., Eisenstadt E., Miller J. H. Base substitution mutations induced by metabolically activated aflatoxin B1. Proc Natl Acad Sci U S A. 1983 May;80(9):2695–2698. doi: 10.1073/pnas.80.9.2695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Fowler M. J., Greenfield C., Chu C. M., Karayiannis P., Dunk A., Lok A. S., Lai C. L., Yeoh E. K., Monjardino J. P., Wankya B. M. Integration of HBV-DNA may not be a prerequisite for the maintenance of the state of malignant transformation. An analysis of 110 liver biopsies. J Hepatol. 1986;2(2):218–229. doi: 10.1016/s0168-8278(86)80080-0. [DOI] [PubMed] [Google Scholar]
  96. Fox T. R., Watanabe P. G. Detection of a cellular oncogene in spontaneous liver tumors of B6C3F1 mice. Science. 1985 May 3;228(4699):596–597. doi: 10.1126/science.3983645. [DOI] [PubMed] [Google Scholar]
  97. Fraiese A., Pontisso P., Cavalletto D., Fattovich G., Alberti A. Expression of preS1 and preS2 in the liver of chronic hepatitis B virus carriers. J Hepatol. 1988 Oct;7(2):157–163. doi: 10.1016/s0168-8278(88)80477-x. [DOI] [PubMed] [Google Scholar]
  98. Francke U., Holmes L. B., Atkins L., Riccardi V. M. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 1979;24(3):185–192. doi: 10.1159/000131375. [DOI] [PubMed] [Google Scholar]
  99. Fu X. X., Su C. Y., Lee Y., Hintz R., Biempica L., Snyder R., Rogler C. E. Insulinlike growth factor II expression and oval cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers. J Virol. 1988 Sep;62(9):3422–3430. doi: 10.1128/jvi.62.9.3422-3430.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991 Jan 1;51(1):89–93. [PubMed] [Google Scholar]
  101. Fujiyama A., Miyanohara A., Nozaki C., Yoneyama T., Ohtomo N., Matsubara K. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res. 1983 Jul 11;11(13):4601–4610. doi: 10.1093/nar/11.13.4601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Fults D., Tippets R. H., Thomas G. A., Nakamura Y., White R. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. Cancer Res. 1989 Dec 1;49(23):6572–6577. [PubMed] [Google Scholar]
  103. Galibert F., Chen T. N., Mandart E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol. 1982 Jan;41(1):51–65. doi: 10.1128/jvi.41.1.51-65.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature. 1979 Oct 25;281(5733):646–650. doi: 10.1038/281646a0. [DOI] [PubMed] [Google Scholar]
  105. Goudeau A., Maupas P., Coursaget P., Drucker J., Chiron J. P., Denis F., Diop Mar I., N'Diaye P. D. Detection of hepatitis B virus antigens in hepatocellular carcinoma tissues. Prog Med Virol. 1981;27:77–87. [PubMed] [Google Scholar]
  106. Green M. R. When the products of oncogenes and anti-oncogenes meet. Cell. 1989 Jan 13;56(1):1–3. doi: 10.1016/0092-8674(89)90975-6. [DOI] [PubMed] [Google Scholar]
  107. Gu J. R. Molecular aspects of human hepatic carcinogenesis. Carcinogenesis. 1988 May;9(5):697–703. doi: 10.1093/carcin/9.5.697. [DOI] [PubMed] [Google Scholar]
  108. Gu J. R., Tian P. K., Wan D. F., Wang X., Li H. N., Pan Z. M., Huang L. H., Li X. Z., Jiang H. Q. Identification of human N-ras as the common oncogene in NIH 3T3 cells transformed with DNAs from human primary hepatic cancer and hepatoma 7402 line. Sci Sin B. 1986 Feb;29(2):173–180. [PubMed] [Google Scholar]
  109. Gudat F., Bianchi L. Evidence for phasic sequences in nuclear HBcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B. Gastroenterology. 1977 Nov;73(5):1194–1197. [PubMed] [Google Scholar]
  110. Haber D. A., Housman D. E. Rate-limiting steps: the genetics of pediatric cancers. Cell. 1991 Jan 11;64(1):5–8. doi: 10.1016/0092-8674(91)90200-i. [DOI] [PubMed] [Google Scholar]
  111. Hadziyannis S. J., Lieberman H. M., Karvountzis G. G., Shafritz D. A. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology. 1983 Sep-Oct;3(5):656–662. doi: 10.1002/hep.1840030505. [DOI] [PubMed] [Google Scholar]
  112. Halpern M. S., Egan J., McMahon S. B., Ewert D. L. Duck hepatitis B virus is tropic for exocrine cells of the pancreas. Virology. 1985 Oct 15;146(1):157–161. doi: 10.1016/0042-6822(85)90064-9. [DOI] [PubMed] [Google Scholar]
  113. Halpern M. S., England J. M., Deery D. T., Petcu D. J., Mason W. S., Molnar-Kimber K. L. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4865–4869. doi: 10.1073/pnas.80.15.4865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988 Jul 1;241(4861):42–52. doi: 10.1126/science.3291115. [DOI] [PubMed] [Google Scholar]
  115. Hansen M. F., Cavenee W. K. Genetics of cancer predisposition. Cancer Res. 1987 Nov 1;47(21):5518–5527. [PubMed] [Google Scholar]
  116. Harbour J. W., Lai S. L., Whang-Peng J., Gazdar A. F., Minna J. D., Kaye F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 1988 Jul 15;241(4863):353–357. doi: 10.1126/science.2838909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Hardell L., Bengtsson N. O., Jonsson U., Eriksson S., Larsson L. G. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer. 1984 Sep;50(3):389–397. doi: 10.1038/bjc.1984.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Harris C. C., Sun T. T. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. Cancer Surv. 1986;5(4):765–780. [PubMed] [Google Scholar]
  119. Haruna Y., Hayashi N., Katayama K., Yuki N., Kasahara A., Sasaki Y., Fusamoto H., Kamada T. Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology. 1991 Mar;13(3):417–421. [PubMed] [Google Scholar]
  120. Hatada I., Tokino T., Ochiya T., Matsubara K. Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Oncogene. 1988 Nov;3(5):537–540. [PubMed] [Google Scholar]
  121. Hayward W. S., Neel B. G., Astrin S. M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981 Apr 9;290(5806):475–480. doi: 10.1038/290475a0. [DOI] [PubMed] [Google Scholar]
  122. Heermann K. H., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W. H. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984 Nov;52(2):396–402. doi: 10.1128/jvi.52.2.396-402.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Henderson J. T., Richmond J., Sumerling M. D. Androgenic-anabolic steroid therapy and hepatocellular carcinoma. Lancet. 1973 Apr 28;1(7809):934–934. doi: 10.1016/s0140-6736(73)91384-6. [DOI] [PubMed] [Google Scholar]
  124. Hess G., Gerlich H., Gerken G., Manns M., Meyer Zum Büschenfelde K. H. Relationship of pre-S encoded antigens in liver and clinical manifestations of chronic hepatitis B infection. Liver. 1987 Oct;7(5):245–250. doi: 10.1111/j.1600-0676.1987.tb00352.x. [DOI] [PubMed] [Google Scholar]
  125. Hino O., Nomura K., Ohtake K., Kawaguchi T., Sugano H., Kitagawa T. Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse. Cancer Genet Cytogenet. 1989 Feb;37(2):273–278. doi: 10.1016/0165-4608(89)90059-9. [DOI] [PubMed] [Google Scholar]
  126. Hino O., Ohtake K., Rogler C. E. Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration. J Virol. 1989 Jun;63(6):2638–2643. doi: 10.1128/jvi.63.6.2638-2643.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Hino O., Shows T. B., Rogler C. E. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8338–8342. doi: 10.1073/pnas.83.21.8338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Hirohashi S., Shimosato Y., Ino Y., Kishi K. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver. J Natl Cancer Inst. 1982 Sep;69(3):565–568. [PubMed] [Google Scholar]
  129. Hohenberger P. Detection of HBs-Ag in the pancreas in cases of pancreatic carcinoma. Hepatogastroenterology. 1984 Oct;31(5):239–241. [PubMed] [Google Scholar]
  130. Honigwachs J., Faktor O., Dikstein R., Shaul Y., Laub O. Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol. 1989 Feb;63(2):919–924. doi: 10.1128/jvi.63.2.919-924.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Hoofnagle J. H., Shafritz D. A., Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology. 1987 Jul-Aug;7(4):758–763. doi: 10.1002/hep.1840070424. [DOI] [PubMed] [Google Scholar]
  132. Hosono S., Lee C. S., Chou M. J., Yang C. S., Shih C. H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene. 1991 Feb;6(2):237–243. [PubMed] [Google Scholar]
  133. Hsu H. C., Lai M. Y., Su I. J., Chen D. S., Chang M. H., Yang P. M., Wu C. Y., Hsieh H. C. Correlation of hepatocyte HBsAg expression with virus replication and liver pathology. Hepatology. 1988 Jul-Aug;8(4):749–754. doi: 10.1002/hep.1840080408. [DOI] [PubMed] [Google Scholar]
  134. Hsu H. C., Wu M. Z., Chang M. H., Su I. J., Chen D. S. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol. 1987 Dec;5(3):260–267. doi: 10.1016/s0168-8278(87)80030-2. [DOI] [PubMed] [Google Scholar]
  135. Hsu H. C., Wu T. T., Sheu J. C., Wu C. Y., Chiou T. J., Lee C. S., Chen D. S. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology. 1989 May;9(5):747–750. doi: 10.1002/hep.1840090515. [DOI] [PubMed] [Google Scholar]
  136. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. doi: 10.1038/350427a0. [DOI] [PubMed] [Google Scholar]
  137. Hsu T., Möröy T., Etiemble J., Louise A., Trépo C., Tiollais P., Buendia M. A. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell. 1988 Nov 18;55(4):627–635. doi: 10.1016/0092-8674(88)90221-8. [DOI] [PubMed] [Google Scholar]
  138. Hu K. Q., Vierling J. M., Siddiqui A. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7140–7144. doi: 10.1073/pnas.87.18.7140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Huang H. J., Yee J. K., Shew J. Y., Chen P. L., Bookstein R., Friedmann T., Lee E. Y., Lee W. H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science. 1988 Dec 16;242(4885):1563–1566. doi: 10.1126/science.3201247. [DOI] [PubMed] [Google Scholar]
  140. Höhne M., Schaefer S., Seifer M., Feitelson M. A., Paul D., Gerlich W. H. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J. 1990 Apr;9(4):1137–1145. doi: 10.1002/j.1460-2075.1990.tb08220.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Imazeki F., Yaginuma K., Omata M., Okuda K., Kobayashi M., Koike K. Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma. J Virol. 1988 Mar;62(3):861–865. doi: 10.1128/jvi.62.3.861-865.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Iqbal M. J., Wilkinson M. L., Johnson P. J., Williams R. Sex steroid receptor proteins in foetal, adult and malignant human liver tissue. Br J Cancer. 1983 Dec;48(6):791–796. doi: 10.1038/bjc.1983.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Ishikawa F., Takaku F., Hayashi K., Nagao M., Sugimura T. Activation of rat c-raf during transfection of hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A. 1986 May;83(10):3209–3212. doi: 10.1073/pnas.83.10.3209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. James C. D., Carlbom E., Nordenskjold M., Collins V. P., Cavenee W. K. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2858–2862. doi: 10.1073/pnas.86.8.2858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Jilbert A. R., Freiman J. S., Gowans E. J., Holmes M., Cossart Y. E., Burrell C. J. Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology. 1987 Jun;158(2):330–338. doi: 10.1016/0042-6822(87)90205-4. [DOI] [PubMed] [Google Scholar]
  146. Johnson P. J., Krasner N., Portmann B., Eddleston A. L., Williams R. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut. 1978 Nov;19(11):1022–1026. doi: 10.1136/gut.19.11.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Jung M. C., Stemler M., Weimer T., Spengler U., Döhrmann J., Hoffmann R., Eichenlaub D., Eisenburg J., Paumgartner G., Riethmüller G. Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus. Hepatology. 1991 Apr;13(4):637–643. [PubMed] [Google Scholar]
  148. Katayama K., Hayashi N., Sasaki Y., Kasahara A., Ueda K., Fusamoto H., Sato N., Chisaka O., Matsubara K., Kamada T. Detection of hepatitis B virus X gene protein and antibody in type B chronic liver disease. Gastroenterology. 1989 Oct;97(4):990–998. doi: 10.1016/0016-5085(89)91508-4. [DOI] [PubMed] [Google Scholar]
  149. Kay A., Mandart E., Trepo C., Galibert F. The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J. 1985 May;4(5):1287–1292. doi: 10.1002/j.1460-2075.1985.tb03774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Kekulé A. S., Lauer U., Meyer M., Caselmann W. H., Hofschneider P. H., Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature. 1990 Feb 1;343(6257):457–461. doi: 10.1038/343457a0. [DOI] [PubMed] [Google Scholar]
  151. Kew M. C., Hodkinson J., Paterson A. C., Song E. Hepatitis-B virus infection in black children with hepatocellular carcinoma. J Med Virol. 1982;9(3):201–207. doi: 10.1002/jmv.1890090307. [DOI] [PubMed] [Google Scholar]
  152. Kew M. C., Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis. 1984 May;4(2):136–146. doi: 10.1055/s-2008-1040653. [DOI] [PubMed] [Google Scholar]
  153. Kew M. C. The development of hepatocellular cancer in humans. Cancer Surv. 1986;5(4):719–739. [PubMed] [Google Scholar]
  154. Kim C. M., Koike K., Saito I., Miyamura T., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 1991 May 23;351(6324):317–320. doi: 10.1038/351317a0. [DOI] [PubMed] [Google Scholar]
  155. Kim C. Y., Bae S. K., Hann H. W., London W. T., Blumberg B. S. Prevalence of HBeAg and anti-HBe in chronic active hepatitis, cirrhosis and primary hepatocellular carcinoma in Korea. Hepatology. 1985 Jan-Feb;5(1):54–56. doi: 10.1002/hep.1840050113. [DOI] [PubMed] [Google Scholar]
  156. Kiyosawa K., Tanaka E., Sodeyama T., Furuta K., Usuda S., Yousuf M., Furuta S. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Jpn J Cancer Res. 1990 Nov;81(11):1089–1091. doi: 10.1111/j.1349-7006.1990.tb02517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Klein G., Klein E. Evolution of tumours and the impact of molecular oncology. Nature. 1985 May 16;315(6016):190–195. doi: 10.1038/315190a0. [DOI] [PubMed] [Google Scholar]
  158. Klein G. The approaching era of the tumor suppressor genes. Science. 1987 Dec 11;238(4833):1539–1545. doi: 10.1126/science.3317834. [DOI] [PubMed] [Google Scholar]
  159. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  160. Knudson A. G., Jr Model hereditary cancers of man. Prog Nucleic Acid Res Mol Biol. 1983;29:17–25. doi: 10.1016/s0079-6603(08)60425-0. [DOI] [PubMed] [Google Scholar]
  161. Koch S., von Loringhoven A. F., Hofschneider P. H., Koshy R. Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA. EMBO J. 1984 Sep;3(9):2185–2189. doi: 10.1002/j.1460-2075.1984.tb02111.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Koike K., Iino S., Kurai K., Mitamura K., Endo Y., Oka H. IgM anti-HBc in anti-HBe positive chronic type B hepatitis with acute exacerbations. Hepatology. 1987 May-Jun;7(3):573–576. doi: 10.1002/hep.1840070326. [DOI] [PubMed] [Google Scholar]
  163. Koike K., Shirakata Y., Yaginuma K., Arii M., Takada S., Nakamura I., Hayashi Y., Kawada M., Kobayashi M. Oncogenic potential of hepatitis B virus. Mol Biol Med. 1989 Apr;6(2):151–160. [PubMed] [Google Scholar]
  164. Koshy R., Koch S., von Loringhoven A. F., Kahmann R., Murray K., Hofschneider P. H. Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell. 1983 Aug;34(1):215–223. doi: 10.1016/0092-8674(83)90152-6. [DOI] [PubMed] [Google Scholar]
  165. Koshy R., Maupas P., Müller R., Hofschneider P. H. Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol. 1981 Nov;57(Pt 1):95–102. doi: 10.1099/0022-1317-57-1-95. [DOI] [PubMed] [Google Scholar]
  166. Koufos A., Hansen M. F., Copeland N. G., Jenkins N. A., Lampkin B. C., Cavenee W. K. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. 1985 Jul 25;316(6026):330–334. doi: 10.1038/316330a0. [DOI] [PubMed] [Google Scholar]
  167. Land H., Parada L. F., Weinberg R. A. Cellular oncogenes and multistep carcinogenesis. Science. 1983 Nov 18;222(4625):771–778. doi: 10.1126/science.6356358. [DOI] [PubMed] [Google Scholar]
  168. Larouze B., Saimot G., Lustbader E. D., London W. T., Werner B. G., Payet M. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet. 1976 Sep 11;2(7985):534–538. doi: 10.1016/s0140-6736(76)91792-x. [DOI] [PubMed] [Google Scholar]
  169. Larouzé B., Blumberg B. S., London W. T., Lustbader E. D., Sankalé M., Payet M. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa. J Natl Cancer Inst. 1977 Jun;58(6):1557–1561. doi: 10.1093/jnci/58.6.1557. [DOI] [PubMed] [Google Scholar]
  170. Lee H. S., Rajagopalan M. S., Vyas G. N. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis. Hepatology. 1988 Sep-Oct;8(5):1116–1120. doi: 10.1002/hep.1840080524. [DOI] [PubMed] [Google Scholar]
  171. Lee T. H., Finegold M. J., Shen R. F., DeMayo J. L., Woo S. L., Butel J. S. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol. 1990 Dec;64(12):5939–5947. doi: 10.1128/jvi.64.12.5939-5947.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Lee W. H., Bookstein R., Hong F., Young L. J., Shew J. Y., Lee E. Y. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987 Mar 13;235(4794):1394–1399. doi: 10.1126/science.3823889. [DOI] [PubMed] [Google Scholar]
  173. Levine A. J. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology. 1990 Aug;177(2):419–426. doi: 10.1016/0042-6822(90)90505-l. [DOI] [PubMed] [Google Scholar]
  174. Levrero M., Balsano C., Natoli G., Avantaggiati M. L., Elfassi E. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2. J Virol. 1990 Jun;64(6):3082–3086. doi: 10.1128/jvi.64.6.3082-3086.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Levrero M., Jean-Jean O., Balsano C., Will H., Perricaudet M. Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology. 1990 Jan;174(1):299–304. doi: 10.1016/0042-6822(90)90079-7. [DOI] [PubMed] [Google Scholar]
  176. Liang T. J., Hasegawa K., Rimon N., Wands J. R., Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 1991 Jun 13;324(24):1705–1709. doi: 10.1056/NEJM199106133242405. [DOI] [PubMed] [Google Scholar]
  177. Lin M. H., Lo S. C. Dimerization of hepatitis B viral X protein synthesized in a cell-free system. Biochem Biophys Res Commun. 1989 Oct 16;164(1):14–21. doi: 10.1016/0006-291x(89)91676-8. [DOI] [PubMed] [Google Scholar]
  178. Lo S. J., Chien M. L., Lee Y. H. Characteristics of the X gene of hepatitis B virus. Virology. 1988 Nov;167(1):289–292. doi: 10.1016/0042-6822(88)90081-5. [DOI] [PubMed] [Google Scholar]
  179. Lohiya G., Pirkle H., Hoefs J., Lohiya S., Ngo V. T. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis. Hepatology. 1985 Sep-Oct;5(5):824–826. doi: 10.1002/hep.1840050519. [DOI] [PubMed] [Google Scholar]
  180. Lok A. S., Hadziyannis S. J., Weller I. V., Karvountzis M. G., Monjardino J., Karayiannis P., Montano L., Thomas H. C. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut. 1984 Nov;25(11):1283–1287. doi: 10.1136/gut.25.11.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. London W. T. Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention. Hum Pathol. 1981 Dec;12(12):1085–1097. doi: 10.1016/s0046-8177(81)80329-2. [DOI] [PubMed] [Google Scholar]
  182. Lutwick L. I. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma. Lancet. 1979 Apr 7;1(8119):755–757. doi: 10.1016/s0140-6736(79)91210-8. [DOI] [PubMed] [Google Scholar]
  183. Mackay J., Steel C. M., Elder P. A., Forrest A. P., Evans H. J. Allele loss on short arm of chromosome 17 in breast cancers. Lancet. 1988 Dec 17;2(8625):1384–1385. doi: 10.1016/s0140-6736(88)90584-3. [DOI] [PubMed] [Google Scholar]
  184. Magnius L. O. Characterization of a new antigen-antibody system associated with hepatitis B. Clin Exp Immunol. 1975 May;20(2):209–216. [PMC free article] [PubMed] [Google Scholar]
  185. Magnius L. O., Espmark J. A. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol. 1972 Nov;109(5):1017–1021. [PubMed] [Google Scholar]
  186. Maguire H. F., Hoeffler J. P., Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science. 1991 May 10;252(5007):842–844. doi: 10.1126/science.1827531. [DOI] [PubMed] [Google Scholar]
  187. Malkin D., Li F. P., Strong L. C., Fraumeni J. F., Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. A. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233–1238. doi: 10.1126/science.1978757. [DOI] [PubMed] [Google Scholar]
  188. Malt R. A., Galdabini J. J., Jeppsson B. W. Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma. World J Surg. 1983 Mar;7(2):247–252. doi: 10.1007/BF01656154. [DOI] [PubMed] [Google Scholar]
  189. Marion P. L., Knight S. S., Ho B. K., Guo Y. Y., Robinson W. S., Popper H. Liver disease associated with duck hepatitis B virus infection of domestic ducks. Proc Natl Acad Sci U S A. 1984 Feb;81(3):898–902. doi: 10.1073/pnas.81.3.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Marion P. L., Oshiro L. S., Regnery D. C., Scullard G. H., Robinson W. S. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci U S A. 1980 May;77(5):2941–2945. doi: 10.1073/pnas.77.5.2941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Marion P. L., Van Davelaar M. J., Knight S. S., Salazar F. H., Garcia G., Popper H., Robinson W. S. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4543–4546. doi: 10.1073/pnas.83.12.4543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Marx J. L. The case of the misplaced gene. Science. 1982 Dec 3;218(4576):983–985. doi: 10.1126/science.7134986. [DOI] [PubMed] [Google Scholar]
  193. Marx J. Many gene changes found in cancer. Science. 1989 Dec 15;246(4936):1386–1388. doi: 10.1126/science.2595361. [DOI] [PubMed] [Google Scholar]
  194. Marx J. The cell cycle: spinning farther afield. Science. 1991 Jun 14;252(5012):1490–1492. doi: 10.1126/science.1828620. [DOI] [PubMed] [Google Scholar]
  195. Mason W. S., Aldrich C., Summers J., Taylor J. M. Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci U S A. 1982 Jul;79(13):3997–4001. doi: 10.1073/pnas.79.13.3997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Mason W. S., Seal G., Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol. 1980 Dec;36(3):829–836. doi: 10.1128/jvi.36.3.829-836.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Matsubara K., Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med. 1990 Jun;7(3):243–260. [PubMed] [Google Scholar]
  198. Mattei M. G., de Thé H., Mattei J. F., Marchio A., Tiollais P., Dejean A. Assignment of the human hap retinoic acid receptor RAR beta gene to the p24 band of chromosome 3. Hum Genet. 1988 Oct;80(2):189–190. doi: 10.1007/BF00702867. [DOI] [PubMed] [Google Scholar]
  199. McLachlan A., Milich D. R., Raney A. K., Riggs M. G., Hughes J. L., Sorge J., Chisari F. V. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol. 1987 Mar;61(3):683–692. doi: 10.1128/jvi.61.3.683-692.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. McMahon G., Davis E. F., Huber L. J., Kim Y., Wogan G. N. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1104–1108. doi: 10.1073/pnas.87.3.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Meadows A. T., Naiman J. L., Valdes-Dapena M. Hepatoma associated with androgen therapy for aplastic anemia. J Pediatr. 1974 Jan;84(1):109–110. doi: 10.1016/s0022-3476(74)80565-2. [DOI] [PubMed] [Google Scholar]
  202. Melbye M., Skinhøj P., Nielsen N. H., Vestergaard B. F., Ebbesen P., Hansen J. P., Biggar R. J. Virus-associated cancers in Greenland: frequent hepatitis B virus infection but low primary hepatocellular carcinoma incidence. J Natl Cancer Inst. 1984 Dec;73(6):1267–1272. [PubMed] [Google Scholar]
  203. Menon A. G., Anderson K. M., Riccardi V. M., Chung R. Y., Whaley J. M., Yandell D. W., Farmer G. E., Freiman R. N., Lee J. K., Li F. P. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5435–5439. doi: 10.1073/pnas.87.14.5435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Menzies-Gow N. Hepatocellular carcinoma associated with oral contraceptives. Br J Surg. 1978 May;65(5):316–317. doi: 10.1002/bjs.1800650507. [DOI] [PubMed] [Google Scholar]
  205. Messing A., Chen H. Y., Palmiter R. D., Brinster R. L. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature. 1985 Aug 1;316(6027):461–463. doi: 10.1038/316461a0. [DOI] [PubMed] [Google Scholar]
  206. Milich D. R., Jones J. E., Hughes J. L., Price J., Raney A. K., McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990 Sep;87(17):6599–6603. doi: 10.1073/pnas.87.17.6599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Miller R. H., Kaneko S., Chung C. T., Girones R., Purcell R. H. Compact organization of the hepatitis B virus genome. Hepatology. 1989 Feb;9(2):322–327. doi: 10.1002/hep.1840090226. [DOI] [PubMed] [Google Scholar]
  208. Miller R. H., Lee S. C., Liaw Y. F., Robinson W. S. Hepatitis B viral DNA in infected human liver and in hepatocellular carcinoma. J Infect Dis. 1985 Jun;151(6):1081–1092. doi: 10.1093/infdis/151.6.1081. [DOI] [PubMed] [Google Scholar]
  209. Miller R. H., Marion P. L., Robinson W. S. Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction. Virology. 1984 Nov;139(1):64–72. doi: 10.1016/0042-6822(84)90330-1. [DOI] [PubMed] [Google Scholar]
  210. Miller R. H., Robinson W. S. Common evolutionary origin of hepatitis B virus and retroviruses. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2531–2535. doi: 10.1073/pnas.83.8.2531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Miller R. H., Robinson W. S. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology. 1984 Sep;137(2):390–399. doi: 10.1016/0042-6822(84)90231-9. [DOI] [PubMed] [Google Scholar]
  212. Mintz B., Fleischman R. A. Teratocarcinomas and other neoplasms as developmental defects in gene expression. Adv Cancer Res. 1981;34:211–278. doi: 10.1016/s0065-230x(08)60243-2. [DOI] [PubMed] [Google Scholar]
  213. Moriyama T., Guilhot S., Klopchin K., Moss B., Pinkert C. A., Palmiter R. D., Brinster R. L., Kanagawa O., Chisari F. V. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 1990 Apr 20;248(4953):361–364. doi: 10.1126/science.1691527. [DOI] [PubMed] [Google Scholar]
  214. Mulligan L. M., Matlashewski G. J., Scrable H. J., Cavenee W. K. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5863–5867. doi: 10.1073/pnas.87.15.5863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Möröy T., Etiemble J., Bougueleret L., Hadchouel M., Tiollais P., Buendia M. A. Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma. Oncogene. 1989 Jan;4(1):59–65. [PubMed] [Google Scholar]
  216. Möröy T., Marchio A., Etiemble J., Trépo C., Tiollais P., Buendia M. A. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature. 1986 Nov 20;324(6094):276–279. doi: 10.1038/324276a0. [DOI] [PubMed] [Google Scholar]
  217. Nagasue N., Yukaya H., Chang Y. C., Ogawa Y., Kohno H., Ito A. Active uptake of testosterone by androgen receptors of hepatocellular carcinoma in humans. Cancer. 1986 Jun 1;57(11):2162–2167. doi: 10.1002/1097-0142(19860601)57:11<2162::aid-cncr2820571114>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  218. Nagasue N., Yukaya H., Hamada T., Hirose S., Kanashima R., Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984 Oct 1;54(7):1461–1465. doi: 10.1002/1097-0142(19841001)54:7<1461::aid-cncr2820540740>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  219. Nagaya T., Nakamura T., Tokino T., Tsurimoto T., Imai M., Mayumi T., Kamino K., Yamamura K., Matsubara K. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev. 1987 Oct;1(8):773–782. doi: 10.1101/gad.1.8.773. [DOI] [PubMed] [Google Scholar]
  220. Nakamura Y., Leppert M., O'Connell P., Wolff R., Holm T., Culver M., Martin C., Fujimoto E., Hoff M., Kumlin E. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science. 1987 Mar 27;235(4796):1616–1622. doi: 10.1126/science.3029872. [DOI] [PubMed] [Google Scholar]
  221. Nakao K., Miyao Y., Ohe Y., Tamaoki T. Involvement of an AFP1-binding site in cell-specific transcription of the pre-S1 region of the human hepatitis B virus surface antigen gene. Nucleic Acids Res. 1989 Dec 11;17(23):9833–9842. doi: 10.1093/nar/17.23.9833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Naumov N. V., Mondelli M., Alexander G. J., Tedder R. S., Eddleston A. L., Williams R. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology. 1984 Jan-Feb;4(1):63–68. doi: 10.1002/hep.1840040111. [DOI] [PubMed] [Google Scholar]
  223. Nayak N. C., Dhar A., Sachdeva R., Mittal A., Seth H. N., Sudarsanam D., Reddy B., Wagholikar U. L., Reddy C. R. Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer. 1977 Nov 15;20(5):643–654. doi: 10.1002/ijc.2910200502. [DOI] [PubMed] [Google Scholar]
  224. Nazarewicz-de Mezer T., Slusarczyk J., Krawczynski K., Nowoslawski A. Localization of hepatitis B virus antigens in hepatocellular carcinoma. Prog Med Virol. 1981;27:66–76. [PubMed] [Google Scholar]
  225. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science. 1987 Sep 11;237(4820):1324–1329. doi: 10.1126/science.2888190. [DOI] [PubMed] [Google Scholar]
  226. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. doi: 10.1038/342705a0. [DOI] [PubMed] [Google Scholar]
  227. Nishioka K., Levin A. G., Simons M. J. Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull World Health Organ. 1975;52(3):293–300. [PMC free article] [PubMed] [Google Scholar]
  228. Obata H., Hayashi N., Motoike Y., Hisamitsu T., Okuda H., Kobayashi S., Nishioka K. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 1980 Jun 15;25(6):741–747. doi: 10.1002/ijc.2910250609. [DOI] [PubMed] [Google Scholar]
  229. Obayashi A., Okochi K., Mayumi M. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology. 1972 Apr;62(4):618–625. [PubMed] [Google Scholar]
  230. Ochiya T., Fujiyama A., Fukushige S., Hatada I., Matsubara K. Molecular cloning of an oncogene from a human hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1986 Jul;83(14):4993–4997. doi: 10.1073/pnas.83.14.4993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Ogston C. W., Jonak G. J., Rogler C. E., Astrin S. M., Summers J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell. 1982 Jun;29(2):385–394. doi: 10.1016/0092-8674(82)90155-6. [DOI] [PubMed] [Google Scholar]
  232. Ohkoshi S., Kojima H., Tawaraya H., Miyajima T., Kamimura T., Asakura H., Satoh A., Hirose S., Hijikata M., Kato N. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res. 1990 Jun-Jul;81(6-7):550–553. doi: 10.1111/j.1349-7006.1990.tb02605.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Ohnishi K., Iida S., Iwama S., Goto N., Nomura F., Takashi M., Mishima A., Kono K., Kimura K., Musha H. The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage. Cancer. 1982 Feb 15;49(4):672–677. doi: 10.1002/1097-0142(19820215)49:4<672::aid-cncr2820490415>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  234. Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976 Apr 1;294(14):746–749. doi: 10.1056/NEJM197604012941402. [DOI] [PubMed] [Google Scholar]
  235. Omata M., Ehata T., Yokosuka O., Hosoda K., Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991 Jun 13;324(24):1699–1704. doi: 10.1056/NEJM199106133242404. [DOI] [PubMed] [Google Scholar]
  236. Omata M., Uchiumi K., Ito Y., Yokosuka O., Mori J., Terao K., Wei-Fa Y., O'Connell A. P., London W. T., Okuda K. Duck hepatitis B virus and liver diseases. Gastroenterology. 1983 Aug;85(2):260–267. [PubMed] [Google Scholar]
  237. Ono Y., Onda H., Sasada R., Igarashi K., Sugino Y., Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res. 1983 Mar 25;11(6):1747–1757. doi: 10.1093/nar/11.6.1747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Ou J. H., Laub O., Rutter W. J. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1578–1582. doi: 10.1073/pnas.83.6.1578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Ou J., Rutter W. J. Hybrid hepatitis B virus-host transcripts in a human hepatoma cell. Proc Natl Acad Sci U S A. 1985 Jan;82(1):83–87. doi: 10.1073/pnas.82.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Palmiter R. D., Chen H. Y., Messing A., Brinster R. L. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 1985 Aug 1;316(6027):457–460. doi: 10.1038/316457a0. [DOI] [PubMed] [Google Scholar]
  241. Pasek M., Goto T., Gilbert W., Zink B., Schaller H., MacKay P., Leadbetter G., Murray K. Hepatitis B virus genes and their expression in E. coli. Nature. 1979 Dec 6;282(5739):575–579. doi: 10.1038/282575a0. [DOI] [PubMed] [Google Scholar]
  242. Pasquinelli C., Garreau F., Bougueleret L., Cariani E., Grzeschik K. H., Thiers V., Croissant O., Hadchouel M., Tiollais P., Bréchot C. Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol. 1988 Feb;62(2):629–632. doi: 10.1128/jvi.62.2.629-632.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Payne G. S., Bishop J. M., Varmus H. E. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature. 1982 Jan 21;295(5846):209–214. doi: 10.1038/295209a0. [DOI] [PubMed] [Google Scholar]
  244. Popper H., Roth L., Purcell R. H., Tennant B. C., Gerin J. L. Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci U S A. 1987 Feb;84(3):866–870. doi: 10.1073/pnas.84.3.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Popper H., Shih J. W., Gerin J. L., Wong D. C., Hoyer B. H., London W. T., Sly D. L., Purcell R. H. Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology. 1981 Mar-Apr;1(2):91–98. doi: 10.1002/hep.1840010202. [DOI] [PubMed] [Google Scholar]
  246. Porter L. E., Elm M. S., Van Thiel D. H., Dugas M. C., Eagon P. K. Characterization and quantitation of human hepatic estrogen receptor. Gastroenterology. 1983 Apr;84(4):704–712. [PubMed] [Google Scholar]
  247. Potter V. R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. Br J Cancer. 1978 Jul;38(1):1–23. doi: 10.1038/bjc.1978.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Raimondo G., Rodinò G., Smedile V., Brancatelli S., Villari D., Longo G., Squadrito G. Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis. J Hepatol. 1990 May;10(3):271–273. doi: 10.1016/0168-8278(90)90131-a. [DOI] [PubMed] [Google Scholar]
  249. Raney A. K., Milich D. R., Easton A. J., McLachlan A. Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol. 1990 May;64(5):2360–2368. doi: 10.1128/jvi.64.5.2360-2368.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Realdi G., Alberti A., Rugge M., Bortolotti F., Rigoli A. M., Tremolada F., Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 1980 Aug;79(2):195–199. [PubMed] [Google Scholar]
  251. Reeve A. E., Eccles M. R., Wilkins R. J., Bell G. I., Millow L. J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature. 1985 Sep 19;317(6034):258–260. doi: 10.1038/317258a0. [DOI] [PubMed] [Google Scholar]
  252. Reeve A. E., Housiaux P. J., Gardner R. J., Chewings W. E., Grindley R. M., Millow L. J. Loss of a Harvey ras allele in sporadic Wilms' tumour. Nature. 1984 May 10;309(5964):174–176. doi: 10.1038/309174a0. [DOI] [PubMed] [Google Scholar]
  253. Reynolds F. H., Jr, Sacks T. L., Deobagkar D. N., Stephenson J. R. Cells nonproductively transformed by Abelson murine leukemia virus express a high molecular weight polyprotein containing structural and nonstructural components. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3974–3978. doi: 10.1073/pnas.75.8.3974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Reynolds S. H., Stowers S. J., Maronpot R. R., Anderson M. W., Aaronson S. A. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci U S A. 1986 Jan;83(1):33–37. doi: 10.1073/pnas.83.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Reynolds S. H., Stowers S. J., Patterson R. M., Maronpot R. R., Aaronson S. A., Anderson M. W. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science. 1987 Sep 11;237(4820):1309–1316. doi: 10.1126/science.3629242. [DOI] [PubMed] [Google Scholar]
  256. Robinson W. S., Klote L., Aoki N. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma. J Med Virol. 1990 May;31(1):18–32. doi: 10.1002/jmv.1890310106. [DOI] [PubMed] [Google Scholar]
  257. Robinson W. S. The genome of hepatitis B virus. Annu Rev Microbiol. 1977;31:357–377. doi: 10.1146/annurev.mi.31.100177.002041. [DOI] [PubMed] [Google Scholar]
  258. Rogler C. E., Sherman M., Su C. Y., Shafritz D. A., Summers J., Shows T. B., Henderson A., Kew M. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science. 1985 Oct 18;230(4723):319–322. doi: 10.1126/science.2996131. [DOI] [PubMed] [Google Scholar]
  259. Rogler C. E., Summers J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from a chronically infected liver. J Virol. 1984 Jun;50(3):832–837. doi: 10.1128/jvi.50.3.832-837.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Roingeard P., Lu S. L., Sureau C., Freschlin M., Arbeille B., Essex M., Romet-Lemonne J. L. Immunocytochemical and electron microscopic study of hepatitis B virus antigen and complete particle production in hepatitis B virus DNA transfected HepG2 cells. Hepatology. 1990 Feb;11(2):277–285. doi: 10.1002/hep.1840110219. [DOI] [PubMed] [Google Scholar]
  261. Ruiz-Opazo N., Chakraborty P. R., Shafritz D. A. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell. 1982 May;29(1):129–136. doi: 10.1016/0092-8674(82)90097-6. [DOI] [PubMed] [Google Scholar]
  262. Sager R. Tumor suppressor genes: the puzzle and the promise. Science. 1989 Dec 15;246(4936):1406–1412. doi: 10.1126/science.2574499. [DOI] [PubMed] [Google Scholar]
  263. Sambamurti K., Callahan J., Luo X., Perkins C. P., Jacobsen J. S., Humayun M. Z. Mechanisms of mutagenesis by a bulky DNA lesion at the guanine N7 position. Genetics. 1988 Dec;120(4):863–873. doi: 10.1093/genetics/120.4.863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Schubach W., Groudine M. Alteration of c-myc chromatin structure by avian leukosis virus integration. Nature. 1984 Feb 23;307(5953):702–708. doi: 10.1038/307702a0. [DOI] [PubMed] [Google Scholar]
  265. Scott J., Cowell J., Robertson M. E., Priestley L. M., Wadey R., Hopkins B., Pritchard J., Bell G. I., Rall L. B., Graham C. F. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature. 1985 Sep 19;317(6034):260–262. doi: 10.1038/317260a0. [DOI] [PubMed] [Google Scholar]
  266. Seeger C., Baldwin B., Hornbuckle W. E., Yeager A. E., Tennant B. C., Cote P., Ferrell L., Ganem D., Varmus H. E. Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host. J Virol. 1991 Apr;65(4):1673–1679. doi: 10.1128/jvi.65.4.1673-1679.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Seeger C., Ganem D., Varmus H. E. Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus. J Virol. 1984 Aug;51(2):367–375. doi: 10.1128/jvi.51.2.367-375.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  268. Seeger C., Marion P. L., Ganem D., Varmus H. E. In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels. J Virol. 1987 Oct;61(10):3241–3247. doi: 10.1128/jvi.61.10.3241-3247.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Sell S., Leffert H. L. An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma. Hepatology. 1982 Jan-Feb;2(1):77–86. doi: 10.1002/hep.1840020113. [DOI] [PubMed] [Google Scholar]
  270. Sell S., Salman J. Light- and electron-microscopic autoradiographic analysis of proliferating cells during the early stages of chemical hepatocarcinogenesis in the rat induced by feeding N-2-fluorenylacetamide in a choline-deficient diet. Am J Pathol. 1984 Feb;114(2):287–300. [PMC free article] [PubMed] [Google Scholar]
  271. Sells M. A., Chen M. L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005–1009. doi: 10.1073/pnas.84.4.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Seto E., Mitchell P. J., Yen T. S. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature. 1990 Mar 1;344(6261):72–74. doi: 10.1038/344072a0. [DOI] [PubMed] [Google Scholar]
  273. Seto E., Yen T. S., Peterlin B. M., Ou J. H. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8286–8290. doi: 10.1073/pnas.85.21.8286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Shafritz D. A., Shouval D., Sherman H. I., Hadziyannis S. J., Kew M. C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med. 1981 Oct 29;305(18):1067–1073. doi: 10.1056/NEJM198110293051807. [DOI] [PubMed] [Google Scholar]
  275. Shaul Y., Rutter W. J., Laub O. A human hepatitis B viral enhancer element. EMBO J. 1985 Feb;4(2):427–430. doi: 10.1002/j.1460-2075.1985.tb03646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Sheiness D., Bishop J. M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J Virol. 1979 Aug;31(2):514–521. doi: 10.1128/jvi.31.2.514-521.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Shih C., Burke K., Chou M. J., Zeldis J. B., Yang C. S., Lee C. S., Isselbacher K. J., Wands J. R., Goodman H. M. Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol. 1987 Nov;61(11):3491–3498. doi: 10.1128/jvi.61.11.3491-3498.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  278. Shih C., Yu M. Y., Li L. S., Shih J. W. Hepatitis B virus propagated in a rat hepatoma cell line is infectious in a primate model. Virology. 1990 Dec;179(2):871–873. doi: 10.1016/0042-6822(90)90158-n. [DOI] [PubMed] [Google Scholar]
  279. Shimoda T., Shikata T., Karasawa T., Tsukagoshi S., Yoshimura M., Sakurai I. Light microscopic localization of hepatitis B virus antigens in the human pancreas. Possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology. 1981 Dec;81(6):998–1005. [PubMed] [Google Scholar]
  280. Shiozawa M., Ochiya T., Hatada I., Imamura T., Okudaira Y., Hiraoka H., Matsubara K. The lca as an onco-fetal gene: its expression in human fetal liver. Oncogene. 1988 May;2(5):523–526. [PubMed] [Google Scholar]
  281. Shirakata Y., Kawada M., Fujiki Y., Sano H., Oda M., Yaginuma K., Kobayashi M., Koike K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res. 1989 Jul;80(7):617–621. doi: 10.1111/j.1349-7006.1989.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  282. Simon D., Munoz S. J., Maddrey W. C., Knowles B. B. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 1990 Apr;45(2):255–260. doi: 10.1016/0165-4608(90)90091-n. [DOI] [PubMed] [Google Scholar]
  283. Slagle B. L., Zhou Y. Z., Butel J. S. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res. 1991 Jan 1;51(1):49–54. [PubMed] [Google Scholar]
  284. Snyder R. L., Tyler G., Summers J. Chronic hepatitis and hepatocellular carcinoma associated with woodchuck hepatitis virus. Am J Pathol. 1982 Jun;107(3):422–425. [PMC free article] [PubMed] [Google Scholar]
  285. Spandau D. F., Lee C. H. trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 1988 Feb;62(2):427–434. doi: 10.1128/jvi.62.2.427-434.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Stanbridge E. J. Case for genetic regulatory elements that control tumorigenic expression in human hybrid cells. Carcinog Compr Surv. 1985;9:81–85. [PubMed] [Google Scholar]
  287. Stemler M., Weimer T., Tu Z. X., Wan D. F., Levrero M., Jung C., Pape G. R., Will H. Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Virol. 1990 Jun;64(6):2802–2809. doi: 10.1128/jvi.64.6.2802-2809.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Stevens C. E., Beasley R. P., Tsui J., Lee W. C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975 Apr 10;292(15):771–774. doi: 10.1056/NEJM197504102921503. [DOI] [PubMed] [Google Scholar]
  289. Summers J., Mason W. S. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell. 1982 Jun;29(2):403–415. doi: 10.1016/0092-8674(82)90157-x. [DOI] [PubMed] [Google Scholar]
  290. Summers J., O'Connell A., Maupas P., Goudeau A., Coursaget P., Drucker J. Hepatitis B virus DNA in primary hepatocellular carcinoma tissue. J Med Virol. 1978;2(3):207–214. doi: 10.1002/jmv.1890020304. [DOI] [PubMed] [Google Scholar]
  291. Summers J., Smolec J. M., Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4533–4537. doi: 10.1073/pnas.75.9.4533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Sureau C., Romet-Lemonne J. L., Mullins J. I., Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell. 1986 Oct 10;47(1):37–47. doi: 10.1016/0092-8674(86)90364-8. [DOI] [PubMed] [Google Scholar]
  293. Suzuki K., Uchida T., Horiuchi R., Shikata T. Localization of hepatitis B surface and core antigens in human hepatocellular carcinoma by immunoperoxidase methods. Replication of complete virions of carcinoma cells. Cancer. 1985 Jul 15;56(2):321–327. doi: 10.1002/1097-0142(19850715)56:2<321::aid-cncr2820560220>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  294. Suzuki K., Uchida T., Shikata T., Moriyama M., Arakawa Y., Mizokami M., Mima F. Expression of pre-S1, pre-S2, S and X peptides in relation to viral replication in livers with chronic hepatitis B. Liver. 1990 Dec;10(6):355–364. doi: 10.1111/j.1600-0676.1990.tb00481.x. [DOI] [PubMed] [Google Scholar]
  295. Swanstrom R., Parker R. C., Varmus H. E., Bishop J. M. Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A. 1983 May;80(9):2519–2523. doi: 10.1073/pnas.80.9.2519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  297. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  298. Szmuness W., Stevens C. E., Zang E. A., Harley E. J., Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology. 1981 Sep-Oct;1(5):377–385. doi: 10.1002/hep.1840010502. [DOI] [PubMed] [Google Scholar]
  299. T'Ang A., Varley J. M., Chakraborty S., Murphree A. L., Fung Y. K. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science. 1988 Oct 14;242(4876):263–266. doi: 10.1126/science.3175651. [DOI] [PubMed] [Google Scholar]
  300. Tabor E., Gerety R. J., Vogel C. L., Bayley A. C., Anthony P. P., Chan C. H., Barker L. F. Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst. 1977 May;58(5):1197–1200. doi: 10.1093/jnci/58.5.1197. [DOI] [PubMed] [Google Scholar]
  301. Tabor E. Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol. 1989 Jan;27(1):1–6. doi: 10.1002/jmv.1890270102. [DOI] [PubMed] [Google Scholar]
  302. Takada S., Gotoh Y., Hayashi S., Yoshida M., Koike K. Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol. 1990 Feb;64(2):822–828. doi: 10.1128/jvi.64.2.822-828.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  303. Takada S., Koike K. Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells. Oncogene. 1989 Feb;4(2):189–193. [PubMed] [Google Scholar]
  304. Takada S., Koike K. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5628–5632. doi: 10.1073/pnas.87.15.5628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  305. Takahashi T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., Pass H., Gazdar A. F., Minna J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989 Oct 27;246(4929):491–494. doi: 10.1126/science.2554494. [DOI] [PubMed] [Google Scholar]
  306. Takayama T., Makuuchi M., Hirohashi S., Sakamoto M., Okazaki N., Takayasu K., Kosuge T., Motoo Y., Yamazaki S., Hasegawa H. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 1990 Nov 10;336(8724):1150–1153. doi: 10.1016/0140-6736(90)92768-d. [DOI] [PubMed] [Google Scholar]
  307. Takeya T., Hanafusa H. Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell. 1983 Mar;32(3):881–890. doi: 10.1016/0092-8674(83)90073-9. [DOI] [PubMed] [Google Scholar]
  308. Tanaka T., Miyamoto H., Hino O., Kitagawa T., Koike M., Iizuka T., Sakamoto H., Ooshima A. Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy. Hum Pathol. 1986 Feb;17(2):202–204. doi: 10.1016/s0046-8177(86)80296-9. [DOI] [PubMed] [Google Scholar]
  309. Theilmann L., Klinkert M. Q., Gmelin K., Salfeld J., Schaller H., Pfaff E. Detection of pre-S1 proteins in serum and liver of HBsAg-positive patients: a new marker for hepatitis B virus infection. Hepatology. 1986 Mar-Apr;6(2):186–190. doi: 10.1002/hep.1840060206. [DOI] [PubMed] [Google Scholar]
  310. Thung S. N., Gerber M. A., Kasambalides E. J., Gilja B. K., Keh W., Gerlich W. H. Demonstration of pre-S polypeptides of hepatitis B virus in infected livers. Hepatology. 1986 Nov-Dec;6(6):1315–1318. doi: 10.1002/hep.1840060615. [DOI] [PubMed] [Google Scholar]
  311. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature. 1985 Oct 10;317(6037):489–495. doi: 10.1038/317489a0. [DOI] [PubMed] [Google Scholar]
  312. Toguchida J., Ishizaki K., Nakamura Y., Sasaki M. S., Ikenaga M., Kato M., Sugimoto M., Kotoura Y., Yamamuro T. Assignment of common allele loss in osteosarcoma to the subregion 17p13. Cancer Res. 1989 Nov 15;49(22):6247–6251. [PubMed] [Google Scholar]
  313. Tokino T., Fukushige S., Nakamura T., Nagaya T., Murotsu T., Shiga K., Aoki N., Matsubara K. Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas. J Virol. 1987 Dec;61(12):3848–3854. doi: 10.1128/jvi.61.12.3848-3854.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  314. Tong M. J., Thursby M. W., Lin J. H., Weissman J. Y., McPeak C. M. Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol. 1981;27:137–147. [PubMed] [Google Scholar]
  315. Tong M. J., Weiner J. M., Ashcavai M. W., Vyas G. N. Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer. 1979 Dec;44(6):2338–2334. doi: 10.1002/1097-0142(197912)44:6<2338::aid-cncr2820440650>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  316. Trent J. M., Stanbridge E. J., McBride H. L., Meese E. U., Casey G., Araujo D. E., Witkowski C. M., Nagle R. B. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science. 1990 Feb 2;247(4942):568–571. doi: 10.1126/science.2300817. [DOI] [PubMed] [Google Scholar]
  317. Trujillo M. A., Letovsky J., Maguire H. F., Lopez-Cabrera M., Siddiqui A. Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3797–3801. doi: 10.1073/pnas.88.9.3797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  318. Tsurimoto T., Fujiyama A., Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci U S A. 1987 Jan;84(2):444–448. doi: 10.1073/pnas.84.2.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  319. Tur-Kaspa R., Burk R. D., Shaul Y., Shafritz D. A. Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1627–1631. doi: 10.1073/pnas.83.6.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Tur-Kaspa R., Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol. 1990 Jul;11(1):34–36. doi: 10.1016/0168-8278(90)90268-v. [DOI] [PubMed] [Google Scholar]
  321. Tuttleman J. S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986 Nov 7;47(3):451–460. doi: 10.1016/0092-8674(86)90602-1. [DOI] [PubMed] [Google Scholar]
  322. Tuttleman J. S., Pugh J. C., Summers J. W. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol. 1986 Apr;58(1):17–25. doi: 10.1128/jvi.58.1.17-25.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  323. Twu J. S., Robinson W. S. Hepatitis B virus X gene can transactivate heterologous viral sequences. Proc Natl Acad Sci U S A. 1989 Mar;86(6):2046–2050. doi: 10.1073/pnas.86.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  324. Twu J. S., Rosen C. A., Haseltine W. A., Robinson W. S. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol. 1989 Jun;63(6):2857–2860. doi: 10.1128/jvi.63.6.2857-2860.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  325. Twu J. S., Schloemer R. H. Transcriptional trans-activating function of hepatitis B virus. J Virol. 1987 Nov;61(11):3448–3453. doi: 10.1128/jvi.61.11.3448-3453.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Uchida T., Suzuki K., Esumi M., Arii M., Shikata T. Influence of aflatoxin B1 intoxication on duck livers with duck hepatitis B virus infection. Cancer Res. 1988 Mar 15;48(6):1559–1565. [PubMed] [Google Scholar]
  327. Ulrich P. P., Bhat R. A., Kelly I., Brunetto M. R., Bonino F., Vyas G. N. A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol. 1990 Oct;32(2):109–118. doi: 10.1002/jmv.1890320208. [DOI] [PubMed] [Google Scholar]
  328. Uriel J. Cancer, retrodifferentiation, and the myth of Faust. Cancer Res. 1976 Nov;36(11 Pt 2):4269–4275. [PubMed] [Google Scholar]
  329. Uy A., Bruss V., Gerlich W. H., Köchel H. G., Thomssen R. Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology. 1986 Nov;155(1):89–96. doi: 10.1016/0042-6822(86)90170-4. [DOI] [PubMed] [Google Scholar]
  330. Vento S., Hegarty J. E., Alberti A., O'Brien C. J., Alexander G. J., Eddleston A. L., Williams R. T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology. 1985 Mar-Apr;5(2):192–197. doi: 10.1002/hep.1840050206. [DOI] [PubMed] [Google Scholar]
  331. Vitvitski-Trépo L., Kay A., Pichoud C., Chevallier P., de Dinechin S., Shamoon B. M., Mandart E., Trépo C., Galibert F. Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology. 1990 Dec;12(6):1278–1283. doi: 10.1002/hep.1840120605. [DOI] [PubMed] [Google Scholar]
  332. Vyas G. N., Blum H. E. Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med. 1984 May;140(5):754–762. [PMC free article] [PubMed] [Google Scholar]
  333. Walker G. J., Hayward N. K., Falvey S., Cooksley W. G. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 1991 Aug 15;51(16):4367–4370. [PubMed] [Google Scholar]
  334. Wang H. P., Rogler C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet. 1988;48(2):72–78. doi: 10.1159/000132593. [DOI] [PubMed] [Google Scholar]
  335. Wang H. P., Rogler C. E. Topoisomerase I-mediated integration of hepadnavirus DNA in vitro. J Virol. 1991 May;65(5):2381–2392. doi: 10.1128/jvi.65.5.2381-2392.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Wang J. Y. From c-abl to v-abl. Nature. 1983 Aug 4;304(5925):400–400. doi: 10.1038/304400a0. [DOI] [PubMed] [Google Scholar]
  337. Wang W. L., London W. T., Feitelson M. A. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res. 1991 Sep 15;51(18):4971–4977. [PubMed] [Google Scholar]
  338. Wang W. L., London W. T., Lega L., Feitelson M. A. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology. 1991 Jul;14(1):29–37. doi: 10.1002/hep.1840140106. [DOI] [PubMed] [Google Scholar]
  339. Weissman B. E., Saxon P. J., Pasquale S. R., Jones G. R., Geiser A. G., Stanbridge E. J. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science. 1987 Apr 10;236(4798):175–180. doi: 10.1126/science.3031816. [DOI] [PubMed] [Google Scholar]
  340. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990 Apr 6;248(4951):76–79. doi: 10.1126/science.2157286. [DOI] [PubMed] [Google Scholar]
  341. Wiseman R. W., Stowers S. J., Miller E. C., Anderson M. W., Miller J. A. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc Natl Acad Sci U S A. 1986 Aug;83(16):5825–5829. doi: 10.1073/pnas.83.16.5825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Witte O. N., Rosenberg N., Paskind M., Shields A., Baltimore D. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc Natl Acad Sci U S A. 1978 May;75(5):2488–2492. doi: 10.1073/pnas.75.5.2488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  343. Wollersheim M., Debelka U., Hofschneider P. H. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene. 1988 Nov;3(5):545–552. [PubMed] [Google Scholar]
  344. Wong D. T., Nath N., Sninsky J. J. Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame. J Virol. 1985 Jul;55(1):223–231. doi: 10.1128/jvi.55.1.223-231.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  345. Wu J. Y., Zhou Z. Y., Judd A., Cartwright C. A., Robinson W. S. The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase. Cell. 1990 Nov 16;63(4):687–695. doi: 10.1016/0092-8674(90)90135-2. [DOI] [PubMed] [Google Scholar]
  346. Wu T. T., Coates L., Aldrich C. E., Summers J., Mason W. S. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology. 1990 Mar;175(1):255–261. doi: 10.1016/0042-6822(90)90206-7. [DOI] [PubMed] [Google Scholar]
  347. Yaginuma K., Kobayashi H., Kobayashi M., Morishima T., Matsuyama K., Koike K. Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children. J Virol. 1987 Jun;61(6):1808–1813. doi: 10.1128/jvi.61.6.1808-1813.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  348. Yaginuma K., Kobayashi H., Yoshida E., Kobayashi M., Koike K. Direct evidence for the expression of integrated hepatitis B virus DNA in human hepatoma tissue. Gan. 1984 Sep;75(9):743–746. [PubMed] [Google Scholar]
  349. Yaginuma K., Kobayashi M., Yoshida E., Koike K. Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4458–4462. doi: 10.1073/pnas.82.13.4458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. Yamada G., Sakamoto Y., Mizuno M., Nishihara T., Kobayashi T., Takahashi T., Nagashima H. Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection. Gastroenterology. 1982 Aug;83(2):348–356. [PubMed] [Google Scholar]
  351. Yang S. S., Modali R., Parks J. B., Taub J. V. Transforming DNA sequences of human hepatocellular carcinomas, their distribution and relationship with hepatitis B virus sequence in human hepatomas. Leukemia. 1988 Dec;2(12 Suppl):102S–113S. [PubMed] [Google Scholar]
  352. Yarrish R. L., Werner B. G., Blumberg B. S. Association of hepatitis B virus infection with hepatocellular carcinoma in American patients. Int J Cancer. 1980 Dec 15;26(6):711–715. doi: 10.1002/ijc.2910260603. [DOI] [PubMed] [Google Scholar]
  353. Yaswen P., Goyette M., Shank P. R., Fausto N. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol. 1985 Apr;5(4):780–786. doi: 10.1128/mcb.5.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. Yee J. K. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science. 1989 Nov 3;246(4930):658–661. doi: 10.1126/science.2554495. [DOI] [PubMed] [Google Scholar]
  355. Yeh F. S., Yu M. C., Mo C. C., Luo S., Tong M. J., Henderson B. E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res. 1989 May 1;49(9):2506–2509. [PubMed] [Google Scholar]
  356. Yokosuka O., Omata M., Zhou Y. Z., Imazeki F., Okuda K. Duck hepatitis B virus DNA in liver and serum of Chinese ducks: integration of viral DNA in a hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5180–5184. doi: 10.1073/pnas.82.15.5180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  357. Yokota J., Wada M., Shimosato Y., Terada M., Sugimura T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9252–9256. doi: 10.1073/pnas.84.24.9252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  358. Yu M. C., Mack T., Hanisch R., Peters R. L., Henderson B. E., Pike M. C. Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res. 1983 Dec;43(12 Pt 1):6077–6079. [PubMed] [Google Scholar]
  359. Zahm P., Hofschneider P. H., Koshy R. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene. 1988 Aug;3(2):169–177. [PubMed] [Google Scholar]
  360. Zaman S. N., Melia W. M., Johnson R. D., Portmann B. C., Johnson P. J., Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. 1985 Jun 15;1(8442):1357–1360. doi: 10.1016/s0140-6736(85)91785-4. [DOI] [PubMed] [Google Scholar]
  361. Zentgraf H., Herrmann G., Klein R., Schranz P., Loncarevic I., Herrmann D., Hübner K., Schröder C. H. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology. 1990;47(2):143–148. doi: 10.1159/000226807. [DOI] [PubMed] [Google Scholar]
  362. Zhang W. D., Hirohashi S., Tsuda H., Shimosato Y., Yokota J., Terada M., Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 1990 Feb;81(2):108–111. doi: 10.1111/j.1349-7006.1990.tb02534.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Zhang Y. J., Chen C. J., Lee C. S., Haghighi B., Yang G. Y., Wang L. W., Feitelson M., Santella R. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis. 1991 Dec;12(12):2247–2252. doi: 10.1093/carcin/12.12.2247. [DOI] [PubMed] [Google Scholar]
  364. Zhou Y. Z., Slagle B. L., Donehower L. A., vanTuinen P., Ledbetter D. H., Butel J. S. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol. 1988 Nov;62(11):4224–4231. doi: 10.1128/jvi.62.11.4224-4231.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES